Imperva, Inc. (IMPV) Tops Q4 EPS by 4c, Guidance Weak
Imperva, Inc. (NYSE: IMPV) reported Q4 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)